Your browser doesn't support javascript.
loading
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting.
Li, Xingchen; Zhang, Peng; Sun, Hao; Han, Lijie; Jiang, Zhongxing; Yu, Jifeng.
Afiliação
  • Li X; Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang P; Department of Orthopedics, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Jilin, China.
  • Sun H; Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Han L; Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Jiang Z; Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yu J; Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Expert Opin Biol Ther ; 23(12): 1193-1195, 2023.
Article em En | MEDLINE | ID: mdl-37852928

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Anticorpos Biespecíficos / Neoplasias Hematológicas / Hematologia / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Anticorpos Biespecíficos / Neoplasias Hematológicas / Hematologia / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article